Comerț cu amănuntul al produselor farmaceutice
| YEAR | NET REVENUE | TOTAL EXPENSES | PROFIT / LOSS | Debts | Employees |
|---|---|---|---|---|---|
| 2024 | 3.68 mil RON | 7.69 mil RON | -4.04 mil RON↓ 1070.8% | 1.93 mil RON | 7 |
| 2023 | 3.60 mil RON | 3.16 mil RON | 416.3 mii RON↓ 32.7% | 1.10 mil RON | 8 |
| 2022 | 3.21 mil RON | 2.56 mil RON | 618.7 mii RON↓ 25.1% | 1.96 mil RON | 8 |
| 2021 | 2.94 mil RON | 2.08 mil RON | 826.3 mii RON↓ 13.1% | 410.1 mii RON | 8 |
| 2019 | 4.03 mil RON | 3.04 mil RON | 950.6 mii RON↑ 46.6% | 708.8 mii RON | 5 |
| 2018 | 3.21 mil RON | 2.53 mil RON | 648.4 mii RON↑ 191.1% | 132.6 mii RON | 3 |
| 2017 | 1.50 mil RON | 1.26 mil RON | 222.7 mii RON↑ 84.8% | 119.1 mii RON | 5 |
| 2016 | 932.5 mii RON | 795.7 mii RON | 120.5 mii RON↓ 35.9% | 81.5 mii RON | 5 |
| 2015 | 729.9 mii RON | 520.2 mii RON | 187.9 mii RON | 73.8 mii RON | 3 |
DOLCA ORSOLYA-INGEBORG
administratorEste sub incidența Legii nr. 85/2014
Faliment
Funcțiune
Founded